紫锥菊1（Echinacea 1）.docVIP

紫锥菊1（Echinacea 1） In recent years, Echinacea has attracted widespread attention both at home and abroad as an immune enhancer and immunomodulator. In this paper, Echinacea plant pharmacological activity and clinical application of a brief summary, and according to the status of Echinacea plant research and analysis, to provide some new ideas for further development of clinical Echinacea plants and utilization. Keywords active constituent; pharmacological action; immunoregulation; safety; Echinacea purpurea; Echinacea (Echinacea) is native to southern North America and Canada, a kind of Echinacea, this genus has about 8 species and several variants, as current drug development there are three main varieties of Echinacea (Echinacea Echinacea purpurea namely), narrow leaf purple Echinacea (Echinacea augustifolia) and white Echinacea (Echinacea pallida). They are mainly used to treat common cold, cough, bronchitis and upper respiratory tract infections and other factors caused by infection, [1]. Modern research shows that Echinacea can enhance the body of bacteria and resistance to viral infection by stimulating the immune system, but also has the role of antibiotics for the relief of allergic symptoms, and has long been used for the treatment of skin infection [2]. It is one of the largest plant drugs in the international market, and has been introduced and cultivated in other parts of europe. In recent years, the introduction and cultivation have been successfully carried out in Beijing, Nanjing and Shanghai. 1 active ingredients Echinacea contains a variety of chemical components, including polysaccharides (polysaccharides), a variety of alkyl amide compounds (alkylamides), caffeic acid derivatives (caffoylphenos), flavonoids, volatile oils, and so on. The three species of Echinacea, echinacea, echinacea, and echinacea are similar in composition and in their active components, and have little difference in their medicinal effects. In pharmacological studies, polysacc